Dana V. Rizk

University of Alabama System — United States

Medicine · Health Sciences

32h-index4.4kcitations173works5.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal Diseases and Glomerulopathies(90), Chronic Kidney Disease and Diabetes(26), Platelet Disorders and Treatments(24), Complement system in diseases(24), Vasculitis and related conditions(16)

Publications164 total

Biomarkers in the Management of Complement-Mediated Kidney Diseases in the Era of Complement Therapeutics
Clinical Journal of the American Society of Nephrology·2025Open Access
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
New England Journal of Medicine·2025· 9 cited
Iptacopan in Patients With IgA Nephropathy From East Asia
Kidney International Reports·2025Open Access
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
New England Journal of Medicine·2025· 11 cited
Fib and Flow: Fibrillary Deposits in the Wake of Myeloproliferative Disease
Journal of the American Society of Nephrology·2025
Evaluating Sibeprenlimab in IgA Nephropathy - Rationale and Baseline Data from the VISIONARY Trial
Kidney International Reports·2025· 1 citedOpen Access
Rare Case of Renal Limited Chronic Thrombotic Microangiopathy and Membranous Nephropathy After Allogenic Hematopoietic Stem-Cell Transplant
Journal of the American Society of Nephrology·2025
ORIGIN 3: A Phase 3 Trial of Atacicept in IgAN
Journal of the American Society of Nephrology·2025
Delayed Presentation of Primary Podocytopathy and Membranoproliferative Glomerulonephritis (MPGN) Pattern of Injury Secondary to Pembrolizumab and Lenvatinib Use
Journal of the American Society of Nephrology·2025
#2808 A mechanistic biopsy study of the effect of iptacopan on immunopathology in patients with IgA nephropathy (IgAN)
Nephrology Dialysis Transplantation·2025Open Access
#1323 Mesangioproliferative activity of IgA1-IgG immune complexes in IgA nephropathy requires complement C3 and can be inhibited by a broad-spectrum kinase inhibitor
Nephrology Dialysis Transplantation·2025Open Access
#1920 Effects of sparsentan after maximized angiotensin receptor blocker (ARB) treatment in patients with IgA nephropathy (IgAN) in the PROTECT trial
Nephrology Dialysis Transplantation·2025Open Access
#2626 Effect of iptacopan discontinuation on proteinuria and complement biomarkers in patients with immunoglobulin A nephropathy (IgAN): a post hoc analysis from a Phase II trial
Nephrology Dialysis Transplantation·2025Open Access
Sibeprenlimab for the Treatment of IgAN: VISIONARY Phase 3 Interim and Prespecified Subgroup Analyses
Journal of the American Society of Nephrology·2025
Rare Case of Macrophage Activation Syndrome Causing Severe Tubulointerstitial Nephritis in Systemic Lupus Erythematosus
Journal of the American Society of Nephrology·2025
Biomarker Insights from the Phase 3 APPLAUSE-IgAN Study: Iptacopan's Proteomic Signature in IgAN
Journal of the American Society of Nephrology·2025
NF-kB Inhibitor Enhances Galactose Deficiency of IgA1 and Modulates Activation of Multiple Transcription Factors in Immortalized B Cells from Patients with IgAN and Healthy Control Participants
Journal of the American Society of Nephrology·2025
Defining Disease Modification in IgA Nephropathy: Toward a Paradigm Shift in Management
Kidney International Reports·2025Open Access
Rare Case of Podocyte Infolding Glomerulopathy in a Patient with Systemic Lupus Erythematosus
Journal of the American Society of Nephrology·2025
#2949 Colocalization of complement C3 and IgA in glomerular immune-complex deposits of patients with IgA nephropathy correlates with the Oxford classification MEST-C scores
Nephrology Dialysis Transplantation·2025Open Access
page 1 of 9Next →

Frequent Co-authors

Jan Novák(12), Bruce A. Julian(10), Jonathan Barratt(10), Richard Lafayette(7), Hernán Trimarchi(7), Brad H. Rovin(6), Michelle Hladunewich(6), Pietro A. Canetta(6), Paul Muntner(6), Krzysztof Kiryluk(6), Hong Zhang(6), Gerald B. Appel(5), Suzanne E. Judd(5), Katherine Twombley(5), Vlado Perkovic(5), Bart Maes(5), Carla Nester(5), Heather N. Reich(4), Debbie S. Gipson(4), Arun Rajasekaran(4)